DK0656889T3 - 9-chloro-prostaglandin esters and amides and their use in the manufacture of drugs - Google Patents

9-chloro-prostaglandin esters and amides and their use in the manufacture of drugs

Info

Publication number
DK0656889T3
DK0656889T3 DK93918946T DK93918946T DK0656889T3 DK 0656889 T3 DK0656889 T3 DK 0656889T3 DK 93918946 T DK93918946 T DK 93918946T DK 93918946 T DK93918946 T DK 93918946T DK 0656889 T3 DK0656889 T3 DK 0656889T3
Authority
DK
Denmark
Prior art keywords
amides
drugs
chloro
manufacture
prostaglandin esters
Prior art date
Application number
DK93918946T
Other languages
Danish (da)
Inventor
Bernd Buchmann
Werner Skuballa
Roland Ekerdt
Fiona Mcdonald
Karl-Heinz Thierauch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19924229051 external-priority patent/DE4229051A1/en
Priority claimed from DE4229048A external-priority patent/DE4229048A1/en
Priority claimed from DE4229050A external-priority patent/DE4229050A1/en
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0656889T3 publication Critical patent/DK0656889T3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns 9-chloroprostaglandin esters and amides of general formula (I), methods of preparing them and their use as drugs.
DK93918946T 1992-08-31 1993-08-31 9-chloro-prostaglandin esters and amides and their use in the manufacture of drugs DK0656889T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19924229051 DE4229051A1 (en) 1992-08-31 1992-08-31 Pharmaceutical prepns. for treatment of elevated intraocular pressure - contg. 9-chloro-prostaglandin derivs.
DE4229048A DE4229048A1 (en) 1992-08-31 1992-08-31 New ester(s) of 9-chloro-prostaglandin(s) - useful in treatment of glaucoma and as diuretic agents
DE4229050A DE4229050A1 (en) 1992-08-31 1992-08-31 New esters and amides of 9-chloro-prostaglandins - useful, e.g., in treatment of glaucoma and as diuretic agents
PCT/DE1993/000809 WO1994005631A1 (en) 1992-08-31 1993-08-31 9-chloroprostaglandin esters and amides and their use in the preparation of drugs

Publications (1)

Publication Number Publication Date
DK0656889T3 true DK0656889T3 (en) 1999-03-22

Family

ID=27204144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93918946T DK0656889T3 (en) 1992-08-31 1993-08-31 9-chloro-prostaglandin esters and amides and their use in the manufacture of drugs

Country Status (7)

Country Link
EP (1) EP0656889B1 (en)
JP (1) JPH08500597A (en)
AT (1) ATE166642T1 (en)
DE (1) DE59308617D1 (en)
DK (1) DK0656889T3 (en)
ES (1) ES2118248T3 (en)
WO (1) WO1994005631A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100266834B1 (en) * 1992-07-24 2000-09-15 우에하라 아끼라 Prostaglandin derivative
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
JP2769294B2 (en) * 1993-12-15 1998-06-25 アルコン ラボラトリーズ インコーポレイテッド Topical ophthalmic compositions and prostaglandin compounds therefor
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US5700835A (en) * 1995-12-22 1997-12-23 Alcon Laboratories, Inc. 3-Oxa-D-prostaglandins for lowering IOP
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
WO1997023226A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure
PL2084124T3 (en) * 2006-10-02 2014-08-29 Techfields Biochem Co Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950027A1 (en) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-CHLORINE PROSTAGLAND DERIVATIVES, METHOD FOR THE PRODUCTION AND USE AS A MEDICINAL PRODUCT
DE3504044A1 (en) * 1985-02-04 1986-08-07 Schering AG, Berlin und Bergkamen, 1000 Berlin 9-HALOGEN PROSTAGLANDIN CLATHRATE AND THEIR USE AS A MEDICINAL PRODUCT
DE3510978A1 (en) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin NEW 9-HALOGEN PROSTAGLANDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
IL87116A (en) * 1987-07-17 1993-03-15 Schering Ag 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same
DE4008925A1 (en) * 1990-03-16 1991-09-19 Schering Ag New clathrates of 9-chloro-prostaglandin(s) with beta-cyclodextrin
DE4036140A1 (en) * 1990-11-09 1992-05-14 Schering Ag 9-HALOGEN-11SS-HYDROXY-PROSTAGLANDIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
EP0656889A1 (en) 1995-06-14
EP0656889B1 (en) 1998-05-27
ES2118248T3 (en) 1998-09-16
WO1994005631A1 (en) 1994-03-17
JPH08500597A (en) 1996-01-23
ATE166642T1 (en) 1998-06-15
DE59308617D1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
DK0760848T3 (en) Lactobacillus strains of human origin, their compositions and their use
NO307968B1 (en) Pyrazolo- and pyrrolopyridines and pharmaceutical mixtures thereof
FI935585A0 (en) Pyrrolopyrimidiner
NO990405L (en) Substituted N- (indole-2-carbonyl) glycinamides and derivatives as antidiabetic agents
TR200200068T2 (en) Mathematical trifluorobutens
ATE148130T1 (en) TYPE IV DIPEPTIDYL AMINOOPEPTIDASE INHIBITORS
DK0758248T3 (en) Formulations for factor IX
CY1105963T1 (en) CAPSOMEPIDIAN VACCINE COMPOSITIONS AND METHODS OF USE
NO954635D0 (en) Ribozyme therapy for HIV infections and AIDS
DK0705100T3 (en) Therapeutically substituted guanidines
DE69021501D1 (en) ANTI-INFLAMMATORY 4-AMINOPHENOL DERIVATIVES.
DK1097173T3 (en) Use of IL-2 peptides and derivatives thereof as therapeutic agents
ATE203519T1 (en) QUINOLINE DERIVATIVES AS ANTIMALARIATIC AGENTS
DE69425820D1 (en) USE OF FERRIOXAMINE-B FOR THE TREATMENT OF SEPTIC SHOCKS
NO964238D0 (en) Halofantrine-free base for the treatment of malaria and mixtures
DK0556322T3 (en) Aminosulfonylurinstof-ACAT inhibitors
DK0656889T3 (en) 9-chloro-prostaglandin esters and amides and their use in the manufacture of drugs
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
FI955118A0 (en) Herbicidal substituted 1-phenyl- or 1-pyridinyl-benzotriazoles
NO970573D0 (en) Yliden compounds and their preparation
ITRM930502A0 (en) PROCEDURE FOR THE PRODUCTION OF R AMINOCARNITINE AND S AMINOCARNITINE.
TR199701298T1 (en) Tetralins.
ATE165594T1 (en) TRIARYLETHYLENE DERIVATIVES FOR THERAPEUTIC USE
DK0635490T3 (en) Process for the preparation of N-ethylcarbazole
BR9808210A (en) Befenyloxazolines dissubstituted